Effectiveness of kanamycin in management of gram-negative septicemia in children with malignant disease.
D004927:Escherichia coli Infections / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007612:Kanamycin / Q000627:therapeutic use*; D007938:Leukemia / Q000150:complications*; D011552:Pseudomonas Infections / Q000188:drug therapy*; D012208:Rhabdomyosarcoma / Q000150:complications*; D018805:Sepsis / Q000188:drug therapy*; D009396:Wilms Tumor / Q000150:complications*
D007612:Kanamycin